Kent W Mouw

Dana-Farber Cancer Institute

NIH Rank #6156
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#6,156
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 4 grants · National rank #6156.

Top grants by award amount

Kent W Mouw's NIH grant portfolio, ranked by award amount.

  • 1R01CA279221-01A1R01
    Dissecting Integrated Cellular Programs Promoting Platinum Resistance and Progression in Bladder Cancer
    $736.8K
    award amount
  • 1R01CA289304-01R01
    Dissecting and Targeting MAPK - PPARG Crosstalk in Bladder Cancer
    $497.5K
    award amount
  • 5R01CA272657-03R01
    Targeting Nucleotide Excision Repair Deficiency to Improve Bladder Sparing Treatment for Muscle Invasive Bladder Cancer
    $411.2K
    award amount
  • 1R21CA288234-01R21
    Investigating Interactions Between Radiation and Antibody-Drug Conjugates in Bladder Cancer
    $206.1K
    award amount

Affiliation

Institutions that have administered grants for Kent W Mouw.

Affiliated with Dana-Farber Cancer Institute (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6156